Bremer Institut für Präventionsforschung und Sozialmedizin (BIPS), Universität Bremen.
Dtsch Arztebl Int. 2012 Feb;109(5):69-75. doi: 10.3238/arztebl.2012.0069. Epub 2012 Feb 3.
The PRISCUS list of potentially inappropriate medications (PIM) for the elderly was published in 2010 and is the first systematically constructed list of this type in Germany. The aim of the present study is to estimate the baseline prevalence of the prescribing of PIM, as defined by the PRISCUS list.
Pseudonymized claims data from three statutory health insurances in Germany, which together covered more than 8 million insurants, for the year 2007 were used to determine the age- and sex-standardized one-year period prevalence of PIM among the elderly, as well as the frequency of PIM prescribing per person. The study population included all insurants who were at least 65 years old and were continuously insured throughout the year 2007 or died during that year.
Of the 804 400 elderly persons in the study population, 201 472 (25.0%) received at least one PIM prescription in 2007. The PIM prevalence was higher in women than in men (32.0% vs. 23.3%) and increased with age. The most commonly prescribed PIM were amitriptyline (2.6%), acetyldigoxin (2.4%), tetrazepam (2.0%), and oxazepam (2.0%). 8.8% of all elderly persons received the same PIM drug four or more times in 2007.
These data show that PIM were frequently prescribed to elderly persons in Germany before the PRISCUS list was published. Medications on the PRISCUS list are not necessarily absolutely contraindicated, and this study contained no information about the individual risk/benefit analyses that may have been carried out before these drugs were prescribed; thus, no conclusion can be drawn about the prevalence of inappropriate prescribing. Further research is needed to validate the PRISCUS list, which was generated by expert consensus, as a basis for therapeutic guidelines in geriatric medicine.
2010 年发布了 PRISCUS 老年人潜在不适当药物清单(PIM),这是德国首次系统构建的此类清单。本研究的目的是估计按照 PRISCUS 清单定义的 PIM 处方的基线流行率。
使用来自德国三家法定健康保险公司的匿名索赔数据,这些保险涵盖了超过 800 万被保险人,用于确定 2007 年老年人中 PIM 的年龄和性别标准化一年期流行率,以及每人 PIM 处方的频率。研究人群包括所有至少 65 岁且在 2007 年全年连续投保或当年死亡的被保险人。
在研究人群的 804400 名老年人中,201472 人(25.0%)在 2007 年至少开了一种 PIM 处方。女性的 PIM 患病率高于男性(32.0%比 23.3%),并随年龄增长而增加。最常开的 PIM 药物是阿米替林(2.6%)、乙酰地高辛(2.4%)、替扎尼定(2.0%)和奥沙西泮(2.0%)。2007 年,8.8%的老年人服用同一种 PIM 药物超过 4 次。
这些数据表明,在 PRISCUS 清单发布之前,德国老年人经常开 PIM 药物。PRISCUS 清单上的药物不一定绝对禁忌,本研究没有包含在开这些药物之前可能进行的个体风险/获益分析的信息;因此,不能得出关于不适当处方流行率的结论。需要进一步研究来验证 PRISCUS 清单,该清单是通过专家共识生成的,作为老年医学治疗指南的基础。